CADMIUM TERATOGENICITY AND ITS RELATIONSHIP WITH METALLOTHIONEIN GENE-EXPRESSION IN MIDGESTATION MOUSE EMBRYOS

被引:35
|
作者
DE, SK
DEY, SK
ANDREWS, GK
机构
[1] UNIV KANSAS, MED CTR,DEPT BIOCHEM & MOLEC BIOL,WHE 4018, 39TH & RAINBOW BLVD, KANSAS CITY, KS 66103 USA
[2] UNIV KANSAS, MED CTR, DEPT OBSTET GYNECOL & PHYSIOL, KANSAS CITY, KS 66103 USA
关键词
Cadmium teratogenicity; Gene regulation; In situ hybridization; Metal ions; Metallothionein; Midgestation mouse embryo; Zinc;
D O I
10.1016/0300-483X(90)90102-M
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As an approach toward understanding the mechanisms by which cadmium (Cd) exerts its teratogenic effects, the expression and metal regulation of the metallothionein (MT) genes in midgestation mouse embryos were studied by Northern blot and in situ hybridization. Maternal injection of a teratogenic dosage of Cd (50 μmol Cd/kg body wt) did not induce MT mRNA in day 10 (D10) CD-1 mouse embryos, whereas zinc (Zn) (50 μmol/kg) was an effective inducer. In contrast, Cd was about 10-fold more potent than Zn at rapidly inducing MT mRNA in D10 embryos incubated in vitro in medium containing micromolar concentrations of these metals. This suggests that following maternal injection, Cd but not Zn is prevented from reaching the D10 embryo and establishes that the embryonic MT genes are not refractory to metal induction, which might have explained the sensitivity of the embryo to Cd. MT mRNA was detected at high levels only in the extraembryonic membranes of D9 embryos exposed to Cd in vivo. On days 9 and 10, no embryonic cell types contained detectable levels of MT mRNA. This mRNA was detected first at low levels in hepatocytes on D11, soon after formation of liver and these levels increased dramatically by D12. Therefore, Cd teratogenicity was not associated with high levels of cell type-specific expression of the MT genes in Cd-sensitive regions of the embryo (neural tube, limb bud), that might have served to target Cd to these cells. Taken together, the results of this study suggest that Cd teratogenicity reflects damage to maternal or extraembryonic tissues. However, the results cannot exclude the possibility that certain cells in the embryo are exceptionally sensitive to low levels of Cd. © 1990.
引用
收藏
页码:89 / 104
页数:16
相关论文
共 50 条
  • [21] In situ analysis of Raidd-beta-galactosidase fusion gene expression in transgenic mouse midgestation embryos
    H. Motaln
    J. McWhir
    S. Horvat
    Transgenic Research, 2005, 14 : 27 - 40
  • [22] ENDOTOXIN INDUCTION OF MURINE METALLOTHIONEIN GENE-EXPRESSION
    DE, SK
    MCMASTER, MT
    ANDREWS, GK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (25) : 15267 - 15274
  • [23] METALLOTHIONEIN GENE-EXPRESSION IN THE PREIMPLANTATION RABBIT BLASTOCYST
    ANDREWS, GK
    LEHMAN, LD
    HUET, YM
    DEY, SK
    JOURNAL OF CELL BIOLOGY, 1986, 103 (05): : A487 - A487
  • [24] REGULATION OF YEAST COPPER METALLOTHIONEIN GENE-EXPRESSION
    BUTT, T
    ECKER, D
    NEEPER, M
    CROOKE, S
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1633 - 1633
  • [25] TERATOGENICITY OF CADMIUM ADMINISTERED INTO AMNIOTIC CAVITY OF ICR-JCL MOUSE EMBRYOS
    KEINO, H
    GOTO, E
    YAMAMURA, H
    MURAKAMI, U
    TERATOLOGY, 1975, 12 (02) : 201 - 201
  • [26] EXPRESSION OF A MOUSE METALLOTHIONEIN GENE IN PLANTS
    PAUTOT, V
    TEPFER, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 61 - 61
  • [27] Nem insights into the mechanisms of cadmium regulation of mouse metallothionein-I gene expression
    Andrews, GK
    Bittel, D
    Dalton, T
    Hu, N
    Chu, W
    Daggett, M
    Li, Q
    Johnson, J
    METALLOTHIONEIN IV, 1999, : 227 - 232
  • [28] Expression of the mouse metallothionein-I gene conferring cadmium resistance in a transgenic cyanobacterium
    Ren, L
    Shi, DJ
    Dai, JX
    Ru, BG
    FEMS MICROBIOLOGY LETTERS, 1998, 158 (01) : 127 - 132
  • [29] GENE-EXPRESSION IN EMBRYOS AND SEEDLINGS OF MAIZE
    BOOTHE, JG
    WALDEN, DB
    MAYDICA, 1990, 35 (03): : 187 - 194
  • [30] GENE-EXPRESSION IN HUMAN PREIMPLANTATION EMBRYOS
    BONDUELLE, ML
    AKHURST, RJ
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 287 - 288